Cargando…
Repurposing of artesunate, an antimalarial drug, as a potential inhibitor of hepatitis E virus
Hepatitis E virus (HEV) is endemic in several developing countries of Africa and Asia. It mainly causes self-limiting waterborne infections, in either sporadic or outbreak form. Recently, HEV was shown to cause chronic infections in immunosuppressed individuals. Ribavirin and interferon, the current...
Autores principales: | Bhise, Neha, Agarwal, Megha, Thakur, Nidhi, Akshay, P. S., Cherian, Sarah, Lole, Kavita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141844/ https://www.ncbi.nlm.nih.gov/pubmed/37115342 http://dx.doi.org/10.1007/s00705-023-05770-1 |
Ejemplares similares
-
In silico and in vitro screening of licensed antimalarial drugs for repurposing as inhibitors of hepatitis E virus
por: Tietcheu Galani, Borris Rosnay, et al.
Publicado: (2021) -
Repurposing antimalarial artesunate for the prophylactic treatment of depression: Evidence from preclinical research
por: Huang, Shihao, et al.
Publicado: (2022) -
Enhancing the antimalarial activity of artesunate
por: Adebayo, J. O., et al.
Publicado: (2020) -
The wisdom of crowds and the repurposing of artesunate as an anticancer drug
por: Augustin, Yolanda, et al.
Publicado: (2015) -
Embryotoxicity and Toxicokinetics of the Antimalarial Artesunate in Rats
por: Chung, Moon-Koo, et al.
Publicado: (2013)